Private equity firm Investindustrial is working with banks on a possible sale of Italian laboratory diagnostics firm Lifebrain in a deal that could value the COVID-19 test supplier at more than 1 billion euros ($1.2 billion), four sources told Reuters.
Investindustrial, advised by JPMorgan and Goldman Sachs, has been approached by interested parties in recent months and could decide to launch an auction process as soon as May, according to the banking sources.
Rome-based Lifebrain focuses on routine and speciality laboratory tests, including COVID-19 ones, and operates through about 360 laboratories in Italy.
By Stephen Jewkes, Elisa Anzolin, Arno Schuetze, Pamela Barbaglia
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.